Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease

被引:17
作者
Diamond, Eli L. [1 ]
Hatzoglou, Vaios [2 ]
Patel, Sneha [3 ]
Abdel-Wahab, Omar [4 ]
Rampal, Raajit [4 ]
Hyman, David M. [4 ]
Holodny, Andrei I. [2 ]
Raj, Ashish [3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, 160 E 53rd St Second Floor Neurol, New York, NY 10022 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA
[3] Well Cornell Med Coll, Dept Radiol, New York, NY USA
[4] Mem Sloan Kettering CancerCtr, Dept Med, Human Oncol & Pathogenesis Program, New York, NY USA
来源
ORPHANET JOURNAL OF RARE DISEASES | 2016年 / 11卷
关键词
Histiocytosis; Erdheim-Chester disease; Brain; MRI; CENTRAL-NERVOUS-SYSTEM; LANGERHANS CELL HISTIOCYTOSIS; SURFACE-BASED ANALYSIS; INFLAMMATION; DEMENTIA; BRAIN; INFLIXIMAB; CYTOKINE; ATROPHY; ALPHA;
D O I
10.1186/s13023-016-0490-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Erdheim-Chester disease (ECD) is a rare non-Langerhans histiocytosis characterized by systemic inflammation and granulomatous infiltration of multiple organs including the central nervous system (CNS), bones, and retroperitoneum. CNS infiltration occurs in one third of patients, but cognitive changes are common in patients without CNS disease. Here we investigate whether there is a neuroanatomic basis to observed cognitive deficits, even in absence of CNS disease. Methods: We present a volumetric analysis of eleven ECD patients without CNS tumors or prior neurotoxic treatments. Results: Compared to age-matched controls, ECD patients have diffuse, bihemispheric reduction in cortical thickness and subcortical gray matter. Conclusions: These findings provide the first corroborating evidence for neurologic disease in ECD patients without direct CNS infiltration.
引用
收藏
页数:6
相关论文
共 23 条
  • [1] Pathology of the central nervous system in Chester-Erdheim disease: Report of three cases
    AdleBiassette, H
    Chetritt, J
    BergemerFouquet, AM
    Wechsler, J
    Mussini, JM
    Gray, F
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (11) : 1207 - 1216
  • [2] Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients
    Arnaud, Laurent
    Gorochov, Guy
    Charlotte, Frederic
    Lvovschi, Virginie
    Parizot, Christophe
    Larsen, Martin
    Ghillani-Dalbin, Pascale
    Hervier, Baptiste
    Kahn, Jean-Emmanuel
    Deback, Claire
    Musset, Lucile
    Amoura, Zahir
    Haroche, Julien
    [J]. BLOOD, 2011, 117 (10) : 2783 - 2790
  • [3] AYLWARD EH, 1995, AM J PSYCHIAT, V152, P987
  • [4] Tumor Necrosis Factor α As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With Infliximab
    Dagna, Lorenzo
    Corti, Angelo
    Langheim, Silvia
    Guglielmi, Barbara
    De Cobelli, Francesco
    Doglioni, Claudio
    Fragasso, Gabriele
    Sabbadini, Maria Grazia
    Ferrarini, Marina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) : E286 - E290
  • [5] Cortical surface-based analysis - I. Segmentation and surface reconstruction
    Dale, AM
    Fischl, B
    Sereno, MI
    [J]. NEUROIMAGE, 1999, 9 (02) : 179 - 194
  • [6] From inflammation to sickness and depression: when the immune system subjugates the brain
    Dantzer, Robert
    O'Connor, Jason C.
    Freund, Gregory G.
    Johnson, Rodney W.
    Kelley, Keith W.
    [J]. NATURE REVIEWS NEUROSCIENCE, 2008, 9 (01) : 46 - 57
  • [7] Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
    Diamond, Eli L.
    Durham, Benjamin H.
    Haroche, Julien
    Yao, Zhan
    Ma, Jing
    Parikh, Sameer A.
    Wang, Zhaoming
    Choi, John
    Kim, Eunhee
    Cohen-Aubart, Fleur
    Lee, Stanley Chun-Wei
    Gao, Yijun
    Micol, Jean-Baptiste
    Campbell, Patrick
    Walsh, Michael P.
    Sylvester, Brooke
    Dolgalev, Igor
    Aminova, Olga
    Heguy, Adriana
    Zappile, Paul
    Nakitandwe, Joy
    Ganzel, Chezi
    Dalton, James D.
    Ellison, David W.
    Estrada-Veras, Juvianee
    Lacouture, Mario
    Gahl, William A.
    Stephens, Philip J.
    Miller, Vincent A.
    Ross, Jeffrey S.
    Ali, Siraj M.
    Briggs, Samuel R.
    Fasan, Omotayo
    Block, Jared
    Heritier, Sebastien
    Donadieu, Jean
    Solit, David B.
    Hyman, David M.
    Baselga, Jose
    Janku, Filip
    Taylor, Barry S.
    Park, Christopher Y.
    Amoura, Zahir
    Dogan, Ahmet
    Emile, Jean-Francois
    Rosen, Neal
    Gruber, Tanja A.
    Abdel-Wahab, Omar
    [J]. CANCER DISCOVERY, 2016, 6 (02) : 154 - 165
  • [8] Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
    Diamond, Eli L.
    Dagna, Lorenzo
    Hyman, David M.
    Cavalli, Giulio
    Janku, Filip
    Estrada-Veras, Juvianee
    Ferrarini, Marina
    Abdel-Wahab, Omar
    Heaney, Mark L.
    Scheel, Paul J.
    Feeley, Nancy K.
    Ferrero, Elisabetta
    McClain, Kenneth L.
    Vaglio, Augusto
    Colby, Thomas
    Arnaud, Laurent
    Haroche, Julien
    [J]. BLOOD, 2014, 124 (04) : 483 - 492
  • [9] TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab
    Ferrero, Elisabetta
    Belloni, Daniela
    Corti, Angelo
    Doglioni, Claudio
    Dagna, Lorenzo
    Ferrarini, Marina
    [J]. RHEUMATOLOGY, 2014, 53 (01) : 198 - 200
  • [10] Cortical surface-based analysis - II: Inflation, flattening, and a surface-based coordinate system
    Fischl, B
    Sereno, MI
    Dale, AM
    [J]. NEUROIMAGE, 1999, 9 (02) : 195 - 207